HotSheets 2009
- Diagnoses of Cancer Decline in the US
- Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009
- Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer
- Index of Articles Appearing in the 2008 Us TOO HotSheets
- Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial
- PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality
- Read more..
- Us TOO Names 2009 Board Officers & Members
- FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer
- Geography’s Role in Medicare Cancer Coverage
- Low-Income Men More Often Diagnosed with Advanced Prostate Cancer
- FDA Commissioner to Step Down
- Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone
- The Doctor’s Note—Dr. Gerald Chodak
- Read more..
- Medicare Widens Drugs It Accepts for Cancer
- Experts Urge Prostate Cancer “Man-o-Gram’
- Prostate Cancer and Neglect of Other Illnesses
- Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer
- Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy
- Donated Items Sought for June Online Auction
- Family History of Prostate Cancer Does Not Affect Treatment Outcomes
- Read more..
- Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study
- Researchers Identify Biomarker for Fatal Prostate Cancer
- Costs Force Cancer Survivors to Pass on Health Care
- Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer
- GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review
- Preventing Prostate Cancer: Good Nutrition May Be Key
- Personalized Calculator for Future Prostate Cancer Risk
- Read more..
- What to Make of the Prostate Cancer Screening Studies
- A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations
- Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda
- PSA Has Higher Predictive Ability in Black Men than in White Men
- Highlights from the 2009 ASCO GU Cancers Symposium
- Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment
- The Doctor’s Note — Dr. Gerald Chodak
- Read more..
- Urologists Support Baseline PSA Test at Age 40
- Provenge® Significantly Improves Survival
- Living and Loving with Prostate Cancer
- Us TOO Seeks Board Member Applications
- Statins May Protect Prostate Health
- Race May Not Be Key in Cancer Disparities
- Gene Variant Linked to Aggressive Cancers
- Agent Orange & Rapidly Recurrent Cancer
- NCI’s Plan to Accelerate Cancer Research
- Read more..
- Signposts Brochure Now Available
- Young Men with Advanced Cancer & Prognosis
- False Positives in Screening Reduced by New Test
- Predicting Prostate Cancer Recurrence
- Combidex® & Lymph Node Metastasis
- Us TOO Seeks Board Member Applications
- Prostate Cancer Yet Another Worry for Women
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
- Read more..
- New Urinary Continence Brochure Available
- Prostate Cancer Patients Should Not Take Selenium
- Test Improves Prediction of Disease Course
- Predicting the Return of Prostate Cancer
- Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium
- Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy
- Prostate Shrinkage May Reveal High-Grade Cancer
- Read more..
- Special Burning Issues Supplement: Identifying Clinically Significant Prostate Cancers
- PCAM Activities
- Study Finds Acceptable Levels of Anxiety in Men Living with Early, Untreated Prostate Cancer
- Heavy Drinking Boosts Prostate Cancer Risk
- Prostatectomy May Not Always Be Necessary
- Awareness of Prostate Cancer in the General Public
- Some Cancer Rates Higher in the Military
- HIFU in the Treatment of Primary Prostate Cancer
- Read more..
- Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT
- Coronary Artery Disease Risks with ADT
- FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
- ‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors
- PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
- Robotic Surgery May Improve Functional Outcome
- Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test
- Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10
- Read more..
- Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer
- Every Mustache Makes a Difference
- New Web-Based Us TOO Prostate Cancer Support Community
- Soy Pills Fail to Prevent Bone Loss
- Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes
- Getting Closer to the Origins of Prostate Cancer
- Protein Tied with Aggressive Prostate Cancer
- 5th Annual Chicago SEA Blue Prostate Cancer Walk
- Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs
- Read more..
- Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International
- AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations
- Dendreon Completes Submission of Biologics License Application for PROVENGE®
- Questions on Breast & Prostate Cancer Screening
- American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged
- FDA Says No to Amgen Bone Drug
- Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer
- Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer
- Read more..